Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$4.8 - $7.67 $1,228 - $1,963
256 Added 371.01%
325 $1,000
Q3 2023

Nov 21, 2023

BUY
$6.81 - $9.74 $469 - $672
69 New
69 $0
Q4 2021

Feb 18, 2022

SELL
$134.56 - $217.97 $3.14 Million - $5.08 Million
-23,320 Closed
0 $0
Q3 2021

Nov 22, 2021

BUY
$177.8 - $270.58 $416,585 - $633,968
2,343 Added 11.17%
23,320 $4.83 Million
Q2 2021

Aug 26, 2021

BUY
$121.0 - $257.67 $1.55 Million - $3.31 Million
12,842 Added 157.86%
20,977 $4.45 Million
Q1 2021

Apr 28, 2021

BUY
$112.98 - $319.93 $689,403 - $1.95 Million
6,102 Added 300.15%
8,135 $1.47 Million
Q4 2020

Jan 28, 2021

SELL
$78.74 - $139.5 $15,826 - $28,039
-201 Reduced 9.0%
2,033 $226,000
Q3 2020

Oct 30, 2020

BUY
$79.44 - $178.51 $8,182 - $18,386
103 Added 4.83%
2,234 $242,000
Q2 2020

Jul 31, 2020

BUY
$13.86 - $83.61 $29,535 - $178,172
2,131 New
2,131 $177,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $745M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.